Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K FILING SEDAR NOTICE OF AGM - Xenon Pharmaceuticals Inc. | xene-8k_20170309.htm |
Exhibit 99.1
|
|
Deana Fuhriman Senior Relationship Manager
American Stock Transfer & Trust Company, LLC Seattle, Washington
Tel: 718.921.8553 Email: dfuhriman@amstock.com www.amstock.com
|
March 9, 2017
|
|
|
|
Alberta Securities Commission |
|
|
British Columbia Securities Commission |
|
|
Ontario Securities Commission |
|
|
|
|
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
|
Date of meeting: |
June 1, 2017 |
|
Record date for notice: |
April 4, 2017 |
|
Record date for voting: |
April 4, 2017 |
|
Beneficial ownership determination date: |
April 4, 2017 |
|
Securities entitled to notice: |
Common Shares |
|
Securities entitled to vote: |
Common Shares |
|
Issuer mailing directly to non objecting beneficial owners: |
No |
|
Issuer will pay for objecting beneficial owner material distribution: |
Yes |
|
Issuer using notice-and-access for registered investors: |
No |
|
Issuer using notice-and-access for non-registered investors: |
No |
|
Notice-and-access stratification criteria: |
N/A |
Yours very truly,
/s/ Deana Fuhriman
Deana Fuhriman
Senior Relationship Manager